Goudreault Marilyn, D'Ambrosio Lisa M, Kean Michelle J, Mullin Michael J, Larsen Brett G, Sanchez Amy, Chaudhry Sidharth, Chen Ginny I, Sicheri Frank, Nesvizhskii Alexey I, Aebersold Ruedi, Raught Brian, Gingras Anne-Claude
Samuel Lunenfeld Research Institute at Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.
Mol Cell Proteomics. 2009 Jan;8(1):157-71. doi: 10.1074/mcp.M800266-MCP200. Epub 2008 Sep 8.
The serine/threonine protein phosphatases are targeted to specific subcellular locations and substrates in part via interactions with a wide variety of regulatory proteins. Understanding these interactions is thus critical to understanding phosphatase function. Using an iterative affinity purification/mass spectrometry approach, we generated a high density interaction map surrounding the protein phosphatase 2A catalytic subunit. This approach recapitulated the assembly of the PP2A catalytic subunit into many different trimeric complexes but also revealed several new protein-protein interactions. Here we define a novel large multiprotein assembly, referred to as the striatin-interacting phosphatase and kinase (STRIPAK) complex. STRIPAK contains the PP2A catalytic (PP2Ac) and scaffolding (PP2A A) subunits, the striatins (PP2A regulatory B''' subunits), the striatin-associated protein Mob3, the novel proteins STRIP1 and STRIP2 (formerly FAM40A and FAM40B), the cerebral cavernous malformation 3 (CCM3) protein, and members of the germinal center kinase III family of Ste20 kinases. Although the function of the CCM3 protein is unknown, the CCM3 gene is mutated in familial cerebral cavernous malformations, a condition associated with seizures and strokes. Our proteomics survey indicates that a large portion of the CCM3 protein resides within the STRIPAK complex, opening the way for further studies of CCM3 biology. The STRIPAK assembly establishes mutually exclusive interactions with either the CTTNBP2 proteins (which interact with the cytoskeletal protein cortactin) or a second subcomplex consisting of the sarcolemmal membrane-associated protein (SLMAP) and the related coiled-coil proteins suppressor of IKKepsilon (SIKE) and FGFR1OP2. We have thus identified several novel PP2A-containing protein complexes, including a large assembly linking kinases and phosphatases to a gene mutated in human disease.
丝氨酸/苏氨酸蛋白磷酸酶部分通过与多种调节蛋白的相互作用靶向特定的亚细胞位置和底物。因此,理解这些相互作用对于理解磷酸酶功能至关重要。我们采用迭代亲和纯化/质谱方法,生成了围绕蛋白磷酸酶2A催化亚基的高密度相互作用图谱。这种方法概括了PP2A催化亚基组装成许多不同的三聚体复合物,但也揭示了几种新的蛋白质-蛋白质相互作用。在这里,我们定义了一种新型的大型多蛋白组装体,称为striatin相互作用磷酸酶和激酶(STRIPAK)复合物。STRIPAK包含PP2A催化(PP2Ac)和支架(PP2A A)亚基、striatins(PP2A调节B'''亚基)、striatin相关蛋白Mob3、新型蛋白STRIP1和STRIP2(以前称为FAM40A和FAM40B)、脑海绵状血管畸形3(CCM3)蛋白以及Ste20激酶生发中心激酶III家族成员。尽管CCM3蛋白的功能尚不清楚,但CCM3基因在家族性脑海绵状血管畸形中发生突变,这种疾病与癫痫和中风有关。我们的蛋白质组学研究表明,CCM3蛋白的很大一部分存在于STRIPAK复合物中,为进一步研究CCM3生物学开辟了道路。STRIPAK组装体与CTTNBP2蛋白(与细胞骨架蛋白皮层肌动蛋白相互作用)或由肌膜相关蛋白(SLMAP)以及IKKepsilon抑制因子(SIKE)和FGFR1OP2相关卷曲螺旋蛋白组成的第二个亚复合物建立相互排斥的相互作用。因此,我们鉴定了几种新型的含PP2A蛋白复合物,包括一个将激酶和磷酸酶与人类疾病中发生突变的基因联系起来的大型组装体。